-
公开(公告)号:US20180148774A1
公开(公告)日:2018-05-31
申请号:US15574750
申请日:2016-05-16
申请人: GODX, INC , THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HUMAN SERVICES
IPC分类号: C12Q1/6834 , B01L3/00 , C12Q1/70 , C12Q1/6888 , C12Q1/6825
CPC分类号: C12Q1/6834 , B01L3/5023 , B01L2200/141 , B01L2300/069 , B01L2400/0406 , C12Q1/00 , C12Q1/6816 , C12Q1/6825 , C12Q1/6888 , C12Q1/689 , C12Q1/701 , G01N15/06 , G01N15/1056 , G01N15/1463 , G01N15/1484 , G01N33/487 , G01N2015/0693 , G01N2015/1006 , Y02A50/51 , Y02A50/52 , Y02A50/53 , Y02A50/58 , C12Q2565/625
摘要: The present invention relates to the rapid and electricity-free, point-of-care, multiplexed detection and quantification of at least one or more nucleic acid sequences from nucleic acids corresponding to a plurality of pathogens or biomarkers using a micropatterned lateral flow device. Rapid and molecular-level sensitive differential diagnosis of a disease condition may be enabled without the need for a delayed laboratory test so that timely treatment can be administered.